Wegovy is a once‑weekly semaglutide (GLP‑1) injection now available in Muscat through select clinics. It mimics appetite hormones to suppress hunger, slow digestion, and support sustained weight loss. Recommended for adults (BMI ≥27 with comorbidities or ≥30) alongside diet and exercise, with dose escalated from 0.25 mg to 2.4 mg.
Responses
(0 comments)